Modalities Powered by ElevateBio
We support the design, development and manufacturing of genetic medicines across cell therapies, viral vectors, and mRNA therapeutics and vaccines. We enable partners across the full product lifecycle, from preclinical development through pivotal clinical trials and commercializations.
// Manufacturing &
Development Services
Driving a Diverse Array of Modalities
Cell Therapies
We provide a full-spectrum solution for cell therapy manufacturing with tools and expertise in place to support across process development, analytical development, CMC regulatory, manufacturing and more. Our experience spans a wide range of modalities, including TCR-T and CAR-T cells, engineered B cells, allogeneic T cell therapies, viral specific T cells, engineered Treg cells, iPSC-based therapies, NK cells, and more.
Viral Vectors
We offer an array of viral vector services to support across all stages of development. Our experience includes lentiviral gene therapies, adeno-associated virus (AAV) gene therapies, and in vivo gene editing therapies.
mRNA Therapeutics & Vaccines
We provide cGMP manufacturing capabilities to accelerate the development and production of mRNA vaccines and genetic medicines. We can support mRNA drug substance and drug product manufacturing, for any stage of development. We provide the infrastructure, expertise, and regulatory support needed to bring your mRNA vaccines and therapeutics to market efficiently.
All the Components to Support Partners Across a Wide Breadth of Advanced Therapeutics
- CAR/TCR T Cell Therapies
- mRNA Vaccines
- Engineered Cell Therapies
- Gene-Edited Allogeneic Therapies
- In Vivo Car T Therapies
- In Vivo Gene Therapies
Partner with ElevateBio®
Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us
